LP
Linda Palczuk
Director

Linda Palczuk insider trades: Avadel Pharmaceuticals (AVDL) stock purchases

Director, Avadel Pharmaceuticals Last trade Jan 21, 2025 28 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
10
Open-market trades
since 2018
3
Companies
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Linda reports to the SEC

Open-market buys and sales

10 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jan 21, 2025AVDL↑ Buy$40K
Dec 6, 2024AVDL↑ Buy$31K
May 9, 2023AVDL↑ Buy$37K
Dec 23, 2022AVDL↑ Buy$14K
May 27, 2022AVDL↑ Buy$16K
Aug 14, 2020AVDL↑ Buy$20K
Dec 3, 2019AVDL↑ Buy$44K
Jan 16, 2019VRCA↑ Buy$32K
Sep 17, 2018VRCA↑ Buy$41K
Jun 19, 2018VRCA↑ Buy$45K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other AVDL insiders

Open-market trades in the last 12 months

About Linda Palczuk's insider trades

Linda Palczuk is a director at Avadel Pharmaceuticals (AVDL). Since Jun 19, 2018, Linda has reported 10 open-market purchases worth $320K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (11 filings), gifts (6 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AVDL insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.